Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Deloitte
Federal Trade Commission
Moodys
Express Scripts
Dow
Colorcon
US Department of Justice

Generated: December 16, 2018

DrugPatentWatch Database Preview

Drug Price Trends for TRIAZOLAM

« Back to Dashboard

Drug Price Trends for TRIAZOLAM

Average Pharmacy Cost for TRIAZOLAM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TRIAZOLAM 0.125 MG TABLET 00054-4858-25 1.44838 EA 2018-12-12
TRIAZOLAM 0.25 MG TABLET 00054-4859-25 1.33127 EA 2018-12-12
TRIAZOLAM 0.125 MG TABLET 59762-3717-04 1.44838 EA 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for TRIAZOLAM

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
TRIAZOLAM 0.125MG TAB Greenstone, Ltd. 59762-3717-04 100 28.70 0.28700 EA 2018-01-01 - 2021-02-28 Big4
TRIAZOLAM 0.125MG TAB Greenstone, Ltd. 59762-3717-04 100 106.65 1.06650 EA 2018-01-01 - 2021-02-28 FSS
TRIAZOLAM 0.125MG TAB Greenstone, Ltd. 59762-3717-09 100 104.00 1.04000 EA 2018-01-01 - 2021-02-28 Big4
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Argus Health
US Army
Fish and Richardson
Dow
Citi
Johnson and Johnson
Teva
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.